Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Androgenetic alopecia linked to COVID-19 severity; drugs reducing androgen receptor activation may help.

Scientists have created a new hair loss treatment using ultrasound to deliver gene-editing particles, which resulted in up to 90% hair regrowth in mice.

Valproic Acid could potentially be used to treat immune-related conditions due to its ability to modify immune cell functions.

LGBT individuals have unique skin health needs, including higher STD risks and side effects from gender-affirming treatments, requiring dermatologists to offer knowledgeable and culturally competent care.

The LRRK2-G2019S mutation in Parkinson's disease has a lifetime penetrance of 25-35%, and finasteride may help reduce symptoms in adult male Tourette syndrome patients.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Female pattern hair loss diagnosed by scalp appearance, treated with combined therapies and targeted approaches.

Finasteride reduces Tourette syndrome symptoms, but results may be limited due to potential biases.

Seborrhea in Parkinson's disease may be linked to hormones, not autonomic impairment.

Hair loss treatments work better with lifestyle changes.

Obese women with PCOS are more likely to have fatty liver disease.

Finasteride for hair loss may cause long-lasting side effects like impotence and low libido, but trials lack proper safety reporting.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Skin reactions to antidepressants are common but usually not serious and can be treated.

The article concludes that advancements in hair cosmetics require dermatologists to stay informed about products and their potential risks, including allergies and higher risks for hairdressers.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

The document suggests creating a validated score to diagnose Cushing's Syndrome and considers plasma steroid profiling as a simpler diagnostic method.

The document concludes that correct diagnosis and management of PCOS are important, and more research is needed on its risks and treatments.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Use finasteride, minoxidil, and follicular unit transplantation for hair loss treatment.

Melatonin may help treat PCOS symptoms in rats.

Using psychological treatments can help manage skin conditions along with regular medical care.

Certain eye surgery complications can be managed effectively, especially in patients who have used specific prostate medications.

The review suggests that understanding and treating the psychological aspect of skin disorders is important and calls for more collaboration in this field.

Neuroactive steroids show promise for treating mental and neurological disorders by targeting GABA_A receptors.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.